vs

Side-by-side financial comparison of Abbott Laboratories (ABT) and Chubb Limited (CB). Click either name above to swap in a different company.

Chubb Limited is the larger business by last-quarter revenue ($15.1B vs $11.5B, roughly 1.3× Abbott Laboratories). Chubb Limited runs the higher net margin — 21.3% vs 15.5%, a 5.8% gap on every dollar of revenue. On growth, Chubb Limited posted the faster year-over-year revenue change (6.3% vs 4.4%). Over the past eight quarters, Chubb Limited's revenue compounded faster (8.1% CAGR vs 7.2%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Chubb Limited is an American–Swiss company incorporated in Zürich, and listed on the New York Stock Exchange (NYSE) where it is a component of the S&P 500. Chubb is a global provider of insurance products covering property and casualty, accident and health, reinsurance, and life insurance and is the largest publicly traded property and casualty insurance company in the world. Chubb operates in 55 countries and territories and in the Lloyd's insurance market in London. Clients of Chubb consist...

ABT vs CB — Head-to-Head

Bigger by revenue
CB
CB
1.3× larger
CB
$15.1B
$11.5B
ABT
Growing faster (revenue YoY)
CB
CB
+1.9% gap
CB
6.3%
4.4%
ABT
Higher net margin
CB
CB
5.8% more per $
CB
21.3%
15.5%
ABT
Faster 2-yr revenue CAGR
CB
CB
Annualised
CB
8.1%
7.2%
ABT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABT
ABT
CB
CB
Revenue
$11.5B
$15.1B
Net Profit
$1.8B
$3.2B
Gross Margin
57.0%
Operating Margin
19.6%
25.0%
Net Margin
15.5%
21.3%
Revenue YoY
4.4%
6.3%
Net Profit YoY
-80.8%
24.7%
EPS (diluted)
$1.01
$8.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABT
ABT
CB
CB
Q4 25
$11.5B
$15.1B
Q3 25
$11.4B
$16.1B
Q2 25
$11.1B
$14.8B
Q1 25
$10.4B
$13.4B
Q4 24
$11.0B
$14.2B
Q3 24
$10.6B
$14.8B
Q2 24
$10.4B
$13.8B
Q1 24
$10.0B
$12.9B
Net Profit
ABT
ABT
CB
CB
Q4 25
$1.8B
$3.2B
Q3 25
$1.6B
$2.8B
Q2 25
$1.8B
$3.0B
Q1 25
$1.3B
$1.3B
Q4 24
$9.2B
$2.6B
Q3 24
$1.6B
$2.3B
Q2 24
$1.3B
$2.2B
Q1 24
$1.2B
$2.1B
Gross Margin
ABT
ABT
CB
CB
Q4 25
57.0%
Q3 25
55.4%
Q2 25
56.4%
Q1 25
56.9%
Q4 24
55.0%
Q3 24
55.8%
Q2 24
55.6%
Q1 24
55.2%
Operating Margin
ABT
ABT
CB
CB
Q4 25
19.6%
25.0%
Q3 25
18.1%
24.1%
Q2 25
18.4%
25.0%
Q1 25
16.3%
12.5%
Q4 24
17.4%
22.0%
Q3 24
17.5%
20.2%
Q2 24
16.1%
19.6%
Q1 24
13.9%
20.4%
Net Margin
ABT
ABT
CB
CB
Q4 25
15.5%
21.3%
Q3 25
14.5%
17.3%
Q2 25
16.0%
20.0%
Q1 25
12.8%
10.0%
Q4 24
84.1%
18.2%
Q3 24
15.5%
15.7%
Q2 24
12.5%
16.1%
Q1 24
12.3%
16.6%
EPS (diluted)
ABT
ABT
CB
CB
Q4 25
$1.01
$8.05
Q3 25
$0.94
$6.99
Q2 25
$1.01
$7.35
Q1 25
$0.76
$3.29
Q4 24
$5.26
$6.31
Q3 24
$0.94
$5.70
Q2 24
$0.74
$5.46
Q1 24
$0.70
$5.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABT
ABT
CB
CB
Cash + ST InvestmentsLiquidity on hand
$8.9B
Total DebtLower is stronger
$12.9B
$15.7B
Stockholders' EquityBook value
$52.1B
$73.8B
Total Assets
$86.7B
$272.3B
Debt / EquityLower = less leverage
0.25×
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABT
ABT
CB
CB
Q4 25
$8.9B
Q3 25
$7.7B
Q2 25
$7.3B
Q1 25
$6.8B
Q4 24
$8.0B
Q3 24
$7.8B
Q2 24
$7.2B
Q1 24
$6.7B
Total Debt
ABT
ABT
CB
CB
Q4 25
$12.9B
$15.7B
Q3 25
$15.7B
Q2 25
$13.5B
Q1 25
$14.5B
Q4 24
$14.1B
$14.4B
Q3 24
$14.6B
Q2 24
$13.2B
Q1 24
$13.2B
Stockholders' Equity
ABT
ABT
CB
CB
Q4 25
$52.1B
$73.8B
Q3 25
$51.0B
$71.9B
Q2 25
$50.6B
$69.4B
Q1 25
$48.8B
$65.7B
Q4 24
$47.7B
$64.0B
Q3 24
$39.8B
$65.8B
Q2 24
$39.3B
$61.0B
Q1 24
$38.8B
$60.5B
Total Assets
ABT
ABT
CB
CB
Q4 25
$86.7B
$272.3B
Q3 25
$84.2B
$270.2B
Q2 25
$84.0B
$261.6B
Q1 25
$81.4B
$251.8B
Q4 24
$81.4B
$246.5B
Q3 24
$74.4B
$250.6B
Q2 24
$73.0B
$238.6B
Q1 24
$72.5B
$234.9B
Debt / Equity
ABT
ABT
CB
CB
Q4 25
0.25×
0.21×
Q3 25
0.22×
Q2 25
0.19×
Q1 25
0.22×
Q4 24
0.30×
0.22×
Q3 24
0.22×
Q2 24
0.22×
Q1 24
0.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABT
ABT
CB
CB
Operating Cash FlowLast quarter
$3.3B
$4.1B
Free Cash FlowOCF − Capex
$2.6B
FCF MarginFCF / Revenue
22.9%
Capex IntensityCapex / Revenue
6.0%
Cash ConversionOCF / Net Profit
1.87×
1.26×
TTM Free Cash FlowTrailing 4 quarters
$7.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABT
ABT
CB
CB
Q4 25
$3.3B
$4.1B
Q3 25
$2.8B
$3.6B
Q2 25
$2.0B
$3.6B
Q1 25
$1.4B
$1.6B
Q4 24
$2.9B
$4.6B
Q3 24
$2.7B
$4.3B
Q2 24
$2.0B
$4.1B
Q1 24
$1.0B
$3.2B
Free Cash Flow
ABT
ABT
CB
CB
Q4 25
$2.6B
Q3 25
$2.3B
Q2 25
$1.5B
Q1 25
$933.0M
Q4 24
$2.1B
Q3 24
$2.1B
Q2 24
$1.4B
Q1 24
$627.0M
FCF Margin
ABT
ABT
CB
CB
Q4 25
22.9%
Q3 25
20.2%
Q2 25
13.9%
Q1 25
9.0%
Q4 24
19.6%
Q3 24
20.2%
Q2 24
13.8%
Q1 24
6.3%
Capex Intensity
ABT
ABT
CB
CB
Q4 25
6.0%
Q3 25
4.4%
Q2 25
4.5%
Q1 25
4.7%
Q4 24
6.6%
Q3 24
5.2%
Q2 24
5.1%
Q1 24
4.0%
Cash Conversion
ABT
ABT
CB
CB
Q4 25
1.87×
1.26×
Q3 25
1.70×
1.30×
Q2 25
1.15×
1.20×
Q1 25
1.07×
1.18×
Q4 24
0.31×
1.77×
Q3 24
1.64×
1.86×
Q2 24
1.51×
1.83×
Q1 24
0.84×
1.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons